Whitney Garrett
Family · Eastman, GANPI 1407597818
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.6% of the total across 147 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 40 manufacturers, the largest accounting for just 10.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,812 and has fallen 90.9% since, to $164 in 2025.
Across 147 payments — averaging $21.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$322
- Seagen Inc.$247
- Amgen$215
- Merck$177
- Novartis$168
- E.r. Squibb & Sons, L.L.C.$129
- plus $2K from 34 others
What the payments were for
- Food & beverage$2,95095%
- Education$1675%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 13 | $322 |
| Seagen Inc. | 10 | $247 |
| Amgen | 13 | $215 |
| Merck | 8 | $177 |
| Novartis | 8 | $168 |
| E.r. Squibb & Sons, L.L.C. | 6 | $129 |
| Pfizer | 7 | $128 |
| Incyte Corporation | 7 | $123 |
| Beigene USA, Inc. | 6 | $121 |
| Johnson & Johnson | 6 | $116 |
| Sumitomo Pharma America, Inc. | 6 | $104 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $95 |
| Bristol Myers Squibb | 4 | $86 |
| Daiichi Sankyo Inc. | 4 | $79 |
| Regeneron Healthcare Solutions, Inc. | 4 | $78 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $76 |
| Genentech USA, Inc. | 4 | $74 |
| Karyopharm Therapeutics Inc. | 3 | $74 |
| Hologic Sales And Service, LLC | 3 | $72 |
| Eisai Inc. | 3 | $69 |
| Exeltis, USA Inc. | 3 | $64 |
| Rigel Pharmaceuticals, Inc. | 2 | $60 |
| AVEO Pharmaceuticals, Inc. | 2 | $48 |
| Astellas Pharma US Inc | 3 | $47 |
| Lilly USA, LLC | 2 | $36 |
| Myriad Genetic Laboratories, Inc. | 1 | $32 |
| GSK | 2 | $29 |
| Exelixis Inc. | 1 | $25 |
| Pharmacosmos Therapeutics Inc. | 1 | $25 |
| Sanofi | 1 | $24 |
| Mirati Therapeutics, Inc. | 1 | $24 |
| Sobi, Inc | 1 | $19 |
| CTI Biopharma Corp. | 1 | $19 |
| Immunogen, Inc. | 1 | $19 |
| Puma Biotechnology, Inc. | 1 | $18 |
| Adaptive Biotechnologies Corporation | 1 | $18 |
| Stemline Therapeutics Inc. | 1 | $16 |
| Exact Sciences | 1 | $14 |
| G1 Therapeutics, Inc. | 1 | $14 |
| AbbVie | 1 | $14 |
How this compares
$3,117 in reported general payments places this provider in the 85th percentile of 6,258 family providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 37 | $1,738 |
| ValacyclovirValacyclovir Hcl | 15 | $213 |
| Fluconazole | 23 | $157 |
| Nystatin-TriamcinoloneNystatin/Triamcinolone Acet | 12 | $133 |
| Metronidazole | 19 | $105 |
Paid to pharmacies, not to this prescriber.
Other family in Eastman
- Allie McAllisterMarietta$299K
- Erin HenryLawrenceville$135K
- Trisha RomanPeachtree City$134K
- Lori ReedMarietta$106K
- Julia BranchCumming$102K
- Hannah BanachWaycross$85K
- Morgan GroothandEvans$81K
- Anna Carolina WrightLilburn$69K
- Jessica FeehanCanton$51K
- Julia ThorneCanton$39K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.